RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis. (2018)
Attributed to:
MICA: BRONCH-UK a multicentre and multidisciplinary partnership grant tackling unmet needs in bronchiectasis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1183/13993003.02053-2017
PubMed Identifier: 29371384
Publication URI: http://europepmc.org/abstract/MED/29371384
Type: Journal Article/Review
Volume: 51
Parent Publication: The European respiratory journal
Issue: 1
ISSN: 0903-1936